跳至主要内容
临床试验/NCT06159179
NCT06159179招募中不适用

Medical Thoracoscopy for Undiagnosed Transudative and Exudative Pleural Effusion

Dr Cipto Mangunkusumo General Hospital2 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2022年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
124
试验地点
2
主要终点
To analyze role of medical thoracoscopy on undiagnosed transudative and exudative pleural effusion patients

研究概览

简要总结

Indonesia is one of country that contributes the most cases of tuberculosis worldwide. Tuberculosis is the most commonly etiology of exudative pleural effusion. There have been many studies about undiagnosed exudative pleural effusion, but there are not many studies about the use of medical thoracoscopy for diagnosing transudative and exudative pleural effusion, especially on biomarkers of C-Reactive Protein (CRP), D-dimer, Adenosine Deaminase (ADA), Antinuclear Antibody (ANA), C3 C4 complements, Cancer Antigen 125 (CA-125), Xpert Mycobacterium Tuberculosis (Xpert MTB), Lupus Erythematosus cell (LE cell), cytology (effusion and smear) and histopathology. Information gained from those biomarkers via thoracenthesis and medical troracoscopy, etiology of exudative and transudative pleural effusion can be detected earlier and clearly, especially etiology of infection, autoimmune, and malignancy that further can be used to reduce patients' hospitalization period, mortality, and to develop the new therapeutic agents.

详细描述

Medical thoracoscopy is a minimally invasive procedure to access pleura with combination of visual and medical instrument. The procedure is performed under local anesthesia and conscious sedation. Medical thoracoscopy plays role in basic diagnotic and therapeutic. The most common indication on basic diagnostic is on pleural effusion case that has primary target to get specific diagnosis when the etiology of pleural effusion is unknown. Pleural effusion is fluid accumulation inside the pleura for about 15-20 ml. Primary aim of pleural effusion diagnosis is to differentiate exudative and transudative effusions based on Light Criteria. Most of time thoracentesis cannot give etiology of exudative and transudative pleural effusion.

Researchers will evaluate subjects based on inclusion and exclusion criteria in Cipto Mangunkusumo Hospital. Furtehrmore, research subjects will be asked for informed consent. Data will be collected based on research form. Researcher will perform medical thoracoscopy to take specimen for analysing CRP, D-dimer, ADA, ANA, C3 C4 complements, Xpert MTB, LE cell, cytology (effusion and smear) and histopathology to detect the etiology of tuberculosis, malignancy or autoimmune.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitalized adult age 18 - 75 years old
  • Willing to be involved in the research
  • Undiagnosed transudative and exudative pleural effusion post-thoracentesis twice on right and left lung
  • Patients can undergo medical thoracoscopy under local anesthesia, based on ATS and BTS guideline

排除标准

  • Pregnant and breastfeeding women
  • Patients in non-invasive ventilation and mechanical ventilator
  • Transudative and exudative pleural effusion with etiology of chronic heart failure, chronic kidney disease, hepatocirrhosis with or without hepatic hydrothorax and hypoalbuminemia.

结局指标

主要结局

To analyze role of medical thoracoscopy on undiagnosed transudative and exudative pleural effusion patients

时间窗: 2 weeks

To investigate whether medical thoracoscopy has a high diagnostic yield in undiagnosed transudative and exudative pleural effusion patients

次要结局

  • To know the prevalency of undiagnosed transudative and exudative pleural effusion.(Up to 12 months)
  • To analyze cytology (effusion and smear) and histopathology on undiagnosed transudative and exudative pleural effusion(Up to 12 months)
  • To know the etiology of infection, autoimmune and malignancy on undiagnosed transudative and exudative pleural effusion(2 weeks)
  • To analyze biomarkers from pleural effusion (ADA, Xpert MTB, LE cell)(Up to 12 months)
  • To analyze biomarkers from blood (CRP, D-dimer, ANA, C3 C4 complements, CA-125) , , cytology (effusion and smear) and histopathology on undiagnoses transudative and exudative pleural effusion(Up to 12 months)

研究者

发起方
Dr Cipto Mangunkusumo General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gurmeet Singh, MD

Head Division Respirology and Critical Illness, Internal Medicine Department, Principal Investigator, Respirology and Critical Illness Consultant

Dr Cipto Mangunkusumo General Hospital

研究点 (2)

Loading locations...

相似试验